Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb;9(1):153-163.
doi: 10.1007/s13300-017-0349-1. Epub 2017 Dec 19.

Hospital Admissions due to Dysglycaemia and Prescriptions of Antidiabetic Medications in England and Wales: An Ecological Study

Affiliations

Hospital Admissions due to Dysglycaemia and Prescriptions of Antidiabetic Medications in England and Wales: An Ecological Study

Abdallah Y Naser et al. Diabetes Ther. 2018 Feb.

Erratum in

Abstract

Introduction: Hypoglycaemia and hyperglycaemia are common adverse events associated with antidiabetic medications. They are also a common cause of hospital admissions for people with diabetes. The objective of the study was to explore the trends in hospital admissions due to hypoglycaemia and hyperglycaemia and in the prescriptions of antidiabetic medications in England and Wales.

Methods: We conducted an observational study during the period 1999-2016. Hospital admission data for patients from all age groups were extracted from the Hospital Episode Statistics database in England and the Patient Episode Database for Wales. Data on prescriptions of antidiabetic medications were extracted from the Prescription Cost Analysis database from 2004 to 2016.

Results: Between 1999 and 2016, the hospital admission rate increased by 173.0% [from 17.2 (95% CI 16.9-17.6) to 47.1 (95% CI 46.5-47.6) per 100,000 persons] for hypoglycaemia and by 147.0% [from 22.8 (95% CI 22.4-23.2) to 56.3 (95% CI 55.7-56.9) per 100,000 persons] for hyperglycaemia. The prescription rate for all antidiabetic medications increased between 2004 and 2016 by 116.0% [from 373.0 (95% CI 373.0-373.0) to 806.0 (95% CI 806.0-806.0) prescriptions per 1000 persons]. There was a parallel increase in the rate of antidiabetic medication prescriptions during the same study period, with correlation coefficients of 0.94 for hypoglycaemia and 0.98 for hyperglycaemia, respectively.

Conclusions: There have been parallel increases in the rate of admissions due to dysglycaemia and the rate of antidiabetic prescriptions in England and Wales. Further analytical studies are required to investigate whether increased admission for dysglycaemia is associated with increased use of antidiabetic medications.

Keywords: Admission rate; Antidiabetic medication; Diabetes mellitus; Hyperglycaemia; Hypoglycaemia; Trend.

PubMed Disclaimer

Figures

Fig. 1a–c
Fig. 1a–c
Hospital admission rates due to dysglycaemia in England and Wales between 1999 and 2016. a Hypoglycaemia and hyperglycaemia admission rates in England and Wales for the total population. b Rates of hospital admissions due to hypoglycaemia across different age groups. c Rates of hospital admissions due to hyperglycaemia across different age groups
Fig. 2
Fig. 2
Prescription rates of antidiabetic medications in England and Wales

References

    1. International Diabetes Federation. IDF diabetes atlas. 7th ed. Brussels: International Diabetes Federation; 2015. p. 16–64.
    1. Hanssen KF. Blood glucose control and microvascular and macrovascular complications in diabetes. Diabetes. 1997;46(2):S101–S103. doi: 10.2337/diab.46.2.S101. - DOI - PubMed
    1. National Institute for Health and Care Excellence. Managing blood glucose in adults with type 2 diabetes. https://pathways.nice.org.uk/pathways/type-2-diabetes-in-adults. Accessed 24 Aug 2017.
    1. National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management. https://www.nice.org.uk/guidance/ng17. Accessed 24 Aug 2017.
    1. Riedel A, et al. Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy. Pharmacotherapy. 2007;27(8):1102–1110. doi: 10.1592/phco.27.8.1102. - DOI - PubMed

LinkOut - more resources